Acquisition (code A) of 3,240 shares at $7.899 per share.
Reporting Person Prudo-Chlebosz Raymond · Transaction Code A
Traded Oct 5, 2026 · Disclosed Oct 16, 2026FILED +11 DAYS
Source: SEC Form 4 · 0001493152-26-047458 · filed 2026-10-16 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Akari Therapeutics Plc (AKTX)." Disclosed 2026-10-16. https://desqlong.com/cards/0001493152-26-047458-2 (retrieved 2026-10-17).